---
title: "Thatch’s $108M Series C at $1B: ICHRA Benefits Hit Unicorn"
description: "Thatch raised $108 million Series C at a $1 billion valuation on September 15, 2026 from Index, a16z, General Catalyst, Scale, and The General Partnership. Company: ARR nearly 7× YoY; 5,000+ employers. Prior Series B was $40M at $410M."
date: 2026-09-16T00:00:00.000Z
source: https://venturecapitaltracker.com/2026-thatch-108m-series-c-1b-index-a16z
---

# Thatch’s $108M Series C at $1B: ICHRA Benefits Hit Unicorn

> Thatch raised $108 million Series C at a $1 billion valuation on September 15, 2026 from Index, a16z, General Catalyst, Scale, and The General Partnership. Company: ARR nearly 7× YoY; 5,000+ employers. Prior Series B was $40M at $410M.

**[Thatch](/startup/thatch-health)** raised **$108 million** Series C at a **$1 billion** valuation on **September 15, 2026**. Named investors include **The General Partnership**, **[Index Ventures](/fund/index-ventures)**, **[Scale Venture Partners](/fund/scale-venture-partners)**, **[General Catalyst](/fund/general-catalyst)**, and **[Andreessen Horowitz](/fund/andreessen-horowitz)**, with strategics **Eli Lilly**, **Paychex**, and **ADP Ventures** joining. Company claims: ARR **nearly 7×** year over year and **more than 5,000** employers. Exact ARR dollars were **not printed**. Prior Series B was **$40 million** at about **$410 million** (~17 months earlier per TechCrunch / PitchBook) ([company](https://thatch.com/v3/blog/thatch-series-c-announcement), [TechCrunch](https://techcrunch.com/2026/09/15/health-benefits-platform-thatch-reaches-1b-valuation-as-healthcare-costs-surge/)).

A non-“AI unicorn” just printed **~$1B** on **ICHRA / CHOICE** distribution — employer health costs and GLP-1 demand are forcing a benefits redesign that looks more like a 401(k) than a group plan.

## Key facts

| Field | Detail |
| --- | --- |
| Company | [Thatch](/startup/thatch-health) ([thatch.com](https://thatch.com)) — consumer-directed health benefits / ICHRA |
| Financing | **$108M** Series C at **$1B** |
| Date | September 15, 2026 |
| Prior | **$40M** Series B at **~$410M** (PitchBook via TC) |
| Employers (company) | **>5,000** |
| ARR | **~7× YoY** growth claim; **dollar ARR not disclosed** |
| Distribution | Gusto, Justworks, Paychex; ADP RUN deepened; Venteur migration (company) |

## Who uses the product — and for what job

**Users:** HR and finance leaders at SMBs through mid-market employers who want a fixed health budget instead of negotiating one group plan; employees who want to pick individual medical/dental/vision and spend leftovers on eligible care (therapy, cash-pay GLP-1s, diagnostics).

**Job:** administer **ICHRA** (rebranded **CHOICE** in company copy) — employers fund tax-free budgets; workers buy plans on Thatch’s marketplace; AI recommendations help match plans; leftover dollars can sit on a Thatch debit card for qualified expenses. **Thatch Market** adds curated wellness vendors (company names Lyra, Function Health).

Payroll embeds (Gusto, Justworks, Paychex, ADP) are the **distribution spine** — not a consumer DTC app.

## Why now

- Employer healthcare cost inflation (TC cites **>8%** projected 2027 jump) makes one-size group plans structurally harder.
- Employee demand for benefits group plans often exclude (notably **GLP-1s**) pushes choice models.
- **7× ARR** claim plus **5,000** employers is the proof investors needed that ICHRA is past “regulatory curiosity.”

## Why Index, a16z, GC — portfolio fit

Company framing lists existing investors **doubling down** rather than a single new lead.

- **[Index Ventures](/fund/index-ventures)** has led prior Thatch rounds and framed the end state as an agent that finds, books, and pays for care (partner quote via PR) — consumer-market rebuild thesis.
- **[a16z](/fund/andreessen-horowitz)** and **[General Catalyst](/fund/general-catalyst)** fit multi-year health / fintech infrastructure bets where regulation unlocks a new product category (ICHRA 2020 → CHOICE).
- **[Scale Venture Partners](/fund/scale-venture-partners)** fits enterprise SaaS scale-ups with clear ACV expansion.
- Strategics (**Lilly**, **Paychex**, **ADP**) signal distribution and pharma adjacency — still **not** proof of preferred economics.

The General Partnership is **editorial only** (

## Competitive map

| Approach | Tradeoff |
| --- | --- |
| Traditional group plans | Simple for HR; weak personalization; annual carrier renegotiation |
| Take Command / Remodel / Zorro | Same ICHRA category; different UX / broker motion |
| HRIS-native benefits | Bundle convenience; may lag specialist ICHRA depth |
| Thatch marketplace + embeds | 5,000+ employers claimed; dollar ARR still opaque |

## What is not proven

- Dollar ARR, contribution margin, or take rate.
- Whether “nearly 7×” is GAAP revenue or ARR definition.
- Win rates vs Take Command / Remodel / Zorro.
- Profitability — not disclosed.

## Practical takeaway

- **Founders (benefits):** Own **payroll distribution** early — Thatch’s Gusto/Justworks/Paychex/ADP embeds are the moat narrative.
- **Investors:** Diligence ICHRA attach and medical loss risk; do not confuse employer count with ARR dollars.
- **Operators / HR:** Relevant if group renewals are spiking and employees want GLP-1 / specialty coverage flexibility.

### Sources

1. [Thatch Series C blog](https://thatch.com/v3/blog/thatch-series-c-announcement)
2. [PR Newswire](https://www.prnewswire.com/news-releases/thatch-raises-108m-at-1b-valuation-as-employers-shift-away-from-traditional-health-plans-302879015.html)
3. [TechCrunch](https://techcrunch.com/2026/09/15/health-benefits-platform-thatch-reaches-1b-valuation-as-healthcare-costs-surge/)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** September 16, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.